Autologous Bone Marrow Stem Cells Infusion for the Treatment of Liver Diseases.
Status:
Unknown status
Trial end date:
2020-10-01
Target enrollment:
Participant gender:
Summary
This study evaluates the effect of autologous bone marrow stem cells infusion (ABMSCi)
therapy for liver diseases.Treatment group will receive ABMSCi and drugs therapy ,while
control group will only receive drugs therapy.